Will Fatty Liver Show Up in Bloodwork?
Not reliably. Fatty liver often does not show up on routine bloodwork, and normal liver enzymes do not rule it out. Many people with fatty liver have liver enzyme levels (ALT and AST) that fall within the normal range, even when fat has built up or scarring has started. Bloodwork can raise suspicion, and certain blood test results can be combined into a score that estimates the risk of scarring, but confirming fatty liver usually takes imaging, such as an ultrasound or a specialized scan called elastography.
This matters because fatty liver is usually silent. The most common form, metabolic dysfunction-associated steatotic liver disease (MASLD), develops alongside insulin resistance, belly fat, prediabetes, and high triglycerides. If you have those risk factors, a normal liver panel is not the end of the question. The full pattern of your labs, your waistline, your blood sugar, and your history gives a far better picture than one enzyme value.
Key Points
Normal enzymes do not rule out fatty liver: In a large primary care study, about 79% of patients flagged as higher risk for liver scarring had normal liver enzymes.
Elevated enzymes are a clue, not a diagnosis: Raised ALT and AST can point toward fatty liver, but they can also come from medications, alcohol, viral hepatitis, and other conditions.
Metabolic labs often say more: High triglycerides, low HDL cholesterol, rising fasting glucose or A1C, and signs of insulin resistance raise the likelihood of fatty liver.
FIB-4 uses routine labs to estimate scarring risk: This score combines age, AST, ALT, and platelet count to help decide who needs further testing.
Imaging confirms it: Ultrasound, CT, and MRI can show fat in the liver, and elastography (such as FibroScan) estimates both fat and scarring.
Biopsy is rarely needed: It remains the most definitive test, but noninvasive tests are usually enough.
Screening is often missed: Many people at higher risk never get the follow-up testing that would catch scarring early.
The cause usually traces back to insulin resistance: Testing should look at what is driving fat into the liver, not only whether it is there.
Understanding Fatty Liver and What Bloodwork Measures
Fatty liver means fat has built up in the liver beyond normal levels. In most people, it is driven by metabolic dysfunction: insulin resistance sends extra fat to the liver and pushes the liver to make more of its own. Over time, some people develop inflammation (called MASH), and ongoing inflammation can lead to scarring (fibrosis) and eventually cirrhosis.
A standard liver panel measures substances released when liver cells are stressed or damaged. ALT and AST are enzymes that leak into the blood when liver cells are injured. Fat alone does not always injure liver cells enough to push these enzymes out of range. That is why many people with fatty liver have normal results. StatPearls, a peer-reviewed clinical reference from the National Library of Medicine, notes that liver enzymes are normal in the majority of people with MASLD.
Other parts of a liver panel, such as bilirubin and albumin, usually stay normal until the liver is significantly damaged. When these change, the disease is often already advanced.
This is why testing for fatty liver works best as a pattern. Liver enzymes, metabolic labs, a scarring risk score, your risk factors, and imaging each fill in part of the picture that a single test leaves out.
Which Tests Actually Detect Fatty Liver
Liver enzymes (ALT and AST)
These are part of a comprehensive metabolic panel or a hepatic function panel. When they are elevated in fatty liver, ALT is usually higher than AST. Elevated enzymes are a reason to look closer. Normal enzymes are not a reason to stop looking if you have metabolic risk factors.
Metabolic labs
Because fatty liver is so closely tied to insulin resistance, the labs that track metabolic health often point toward it before the liver panel does:
Fasting glucose, A1C, and Fasting Insulin: Rising values suggest insulin resistance or prediabetes.
Triglycerides and HDL cholesterol: High triglycerides and low HDL often travel with fatty liver.
FIB-4 score
FIB-4 is a calculation, not a separate blood draw. It combines your age, AST, ALT, and platelet count to estimate your risk of advanced liver scarring. A low score makes advanced scarring unlikely. An indeterminate or high score means you need further testing. Because it uses routine labs, it can be calculated from bloodwork many people already have. A large study of primary care patients found that most people flagged as indeterminate or high risk by FIB-4 had normal liver enzymes, and very few of them received follow-up testing.
Imaging
Ultrasound: Often the first scan used. It can show fat in the liver, but it is less sensitive when fat levels are mild.
Elastography (such as FibroScan): A quick, painless scan that estimates liver stiffness, which reflects scarring, and can also estimate fat.
MRI: Can measure liver fat precisely, and MR elastography can assess scarring. It is more costly and usually used when other results are unclear.
No imaging test can directly show liver inflammation, so imaging and bloodwork are interpreted together.
Liver biopsy
A biopsy is the most definitive test and can show inflammation and the stage of scarring. Because noninvasive tests are usually enough, biopsy is reserved for cases where the diagnosis or stage is unclear.
Why fatty liver gets missed
Fatty liver gets missed for three common reasons. Liver enzymes are normal, so no one looks further. Metabolic labs are each “borderline,” so no one connects them. And the factors that drive insulin resistance, such as poor sleep, chronic stress, blood sugar swings, and years of eating patterns built on refined carbohydrates and sugary drinks, are never part of the conversation. A normal liver panel in someone with a growing waistline, rising triglycerides, and creeping blood sugar deserves a closer look.
How Agape approaches liver testing
At Agape Integrative Medicine, lab work is reviewed as a pattern rather than one value at a time. Laboratory testing, including blood chemistry, liver markers, metabolic markers, and thyroid testing, is used when it helps answer a specific question, such as whether insulin resistance is feeding fat into the liver. Your history matters just as much: when your weight, energy, or labs started to change, what you have already tried, and what is happening with your sleep, stress, and digestion. If imaging or specialist follow-up is needed, you will know why. If you have been told your labs are normal but you have risk factors for fatty liver, you can book a new patient appointment.
Who It’s For and Who Should Be Cautious
This information is most useful for adults with risk factors for fatty liver: insulin resistance, prediabetes or type 2 diabetes, extra weight around the middle, high triglycerides, low HDL cholesterol, or high blood pressure. It is especially relevant if you have been told your liver panel is normal but still have several of these risk factors, or if an ultrasound done for another reason mentioned a “fatty” liver. People who want to understand what their full set of labs is saying tend to do well with Agape’s functional medicine approach.
Some caution applies. Elevated liver enzymes have many possible causes, including viral hepatitis, alcohol, medications, supplements, autoimmune liver disease, and inherited conditions, and those need to be ruled out by a medical provider. A FIB-4 score is a screening tool and is less accurate in younger adults and in older adults, so results should be interpreted by a provider. If you already have signs of advanced liver disease or cirrhosis, testing and care should be led by a gastroenterologist or hepatologist. Home or online tests marketed for “liver health” cannot diagnose fatty liver.
Risks, Side Effects, and Monitoring
The biggest risk is false reassurance. A normal liver panel can lead people with real risk factors to assume their liver is fine while fat and scarring progress quietly. Fatty liver can advance to cirrhosis and liver cancer, and it is linked to a higher risk of heart disease and type 2 diabetes.
The tests themselves are low risk. Blood draws and ultrasound or elastography scans are noninvasive. MRI is safe for most people but is not suitable for some implanted devices. Liver biopsy carries a small risk of bleeding and pain, which is one reason it is reserved for unclear cases.
Monitoring over time shows which direction the liver is heading. Liver enzymes, metabolic labs, and FIB-4 can be rechecked at reasonable intervals, and imaging may be repeated if your provider recommends it. Improvements in triglycerides, blood sugar, and waist measurement often signal that the liver is responding too.
These are individualized decisions best made with a knowledgeable provider. Medications and supplements should not be started, stopped, or combined without guidance from the provider who prescribes them, and some herbal products can damage the liver.
Safety
Seek prompt medical care if you notice yellowing of your skin or the whites of your eyes, dark urine, pale stools, swelling in your belly or legs, easy bruising or bleeding, or unexplained weight loss. These can be signs of advanced liver disease, and they need evaluation even if a previous liver panel was normal.
Call 911 or go to the emergency room if you vomit blood or material that looks like coffee grounds, have black or tarry stools, or become confused, very drowsy, or hard to wake.
Pain in the upper right side of your abdomen, especially with fever or nausea, should be evaluated promptly. Gallbladder problems and other conditions can cause similar pain.
Do not take supplements, herbal remedies, or high doses of over-the-counter pain relievers such as acetaminophen without checking with your provider if you have, or may have, liver disease.
Do not stop or change any prescribed medication on your own.
Sources and Citations
Cleveland Clinic — Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Symptoms & Causes of NAFLD & NASH
StatPearls (NCBI Bookshelf) — Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
ACP Gastroenterology — FIB-4 May Identify Patients at Risk for MASLD Despite Normal Aminotransferase Levels
Reviewed By Dr. Jordan Robertson, DC
Last updated: October 2026